Lodoxamide


Generic Medicine Info
Indications and Dosage
Ophthalmic
Allergic conjunctivitis
Adult: As 0.1% soln: Instill 1-2 drops into affected eye(s) 4 times daily.
Child: ≥4 yr Same as adult dose.
Special Precautions
Childn. Pregnancy and lactation.
Adverse Reactions
Significant: Eye irritation (e.g. burning, stinging, discomfort), blurred vision or visual disturbances.
Nervous: Headache, dizziness, drowsiness, somnolence.
GI: Nausea, stomach discomfort.
Resp: Dry nose, sneezing.
Ophthalmologic: Eye itching, foreign body sensation of eye, dry eye, crystalline eye deposit, lacrimation, ocular hyperaemia, ocular oedema, xerophthalmia, asthenopia, blepharitis, chemosis, corneal abrasion, corneal erosion, corneal ulcer, epitheliopathy, eye pain, keratitis, ocular warming sensation, swelling of eye.
Dermatologic: Skin rash.
Patient Counseling Information
This drug may cause temporary blurred vision or visual disturbances, if affected, do not drive or operate machinery. Remove contact lenses prior to ophth admin and reinsert after 15 min.
Action
Description: Lodoxamide is a mast cell stabiliser that inhibits release and activation of inflammatory mediators (e.g. histamine, leukotrienes) from conjunctival tissues thus inhibiting type 1 immediate hypersensitivity reactions.
Pharmacokinetics:
Excretion: Mainly via urine, 83%. Elimination half-life: 8.5 hr.
Chemical Structure

Chemical Structure Image
Lodoxamide

Source: National Center for Biotechnology Information. PubChem Database. Lodoxamide, CID=44564, https://pubchem.ncbi.nlm.nih.gov/compound/Lodoxamide (accessed on Jan. 22, 2020)

Storage
Store below 25°C. Do not freeze.
MIMS Class
Antihistamines & Antiallergics / Ophthalmic Decongestants, Anesthetics, Anti-Inflammatories
ATC Classification
S01GX05 - lodoxamide ; Belongs to the class of other ophthalmologic antiallergics.
References
Anon. Lodoxamide. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 05/07/2017.

Buckingham R (ed). Lodoxamide. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 05/07/2017.

Joint Formulary Committee. Lodoxamide. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 05/07/2017.

McEvoy GK, Snow EK, Miller J et al (eds). Lodoxamide Tromethamine (EENT). AHFS Drug Information (AHFS DI) [online]. American Society of Health-System Pharmacists (ASHP). https://www.medicinescomplete.com. Accessed 05/07/2017.

Disclaimer: This information is independently developed by MIMS based on Lodoxamide from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in